Minerva Neurosciences (NERV) Tops Q3 EPS by 398c

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of $2.97, $3.98 better than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Royal Caribbean Nears Deal For Sandals - FT
• Kroger outlines AI strategy at GroceryShop 2026 conference
• Grab Holdings (GRAB) call put ratio 7.2 calls to 1 put with a focus on November 4 and April 6 calls, share price up 8.2%